Omeros Corporation Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Omeros Corp. (OMER) PT Raised to $32 at Maxim Group
August 10, 2018 7:50 AM EDTMaxim Group raised its price target on Omeros Corp. (NASDAQ: OMER) to $32.00 (from $25.00) while maintaining a Buy rating.
Analsyt Jason McCarthy notes valuation has risen significantly since the end of 1Q18 with resolution of the pass-through status for Omidria, which should... More
Omeros (OMER) Misses Q2 EPS by 1c
August 9, 2018 4:44 PM EDTOmeros (NASDAQ: OMER) reported Q2 EPS of ($0.70), $0.01 worse than the analyst estimate of ($0.69).
During the last quarter, we made significant strides across multiple fronts, said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. For OMS721, our MASP-2 inhibitor, Phase 3... More



